Using multiband fMRI acquisition sequences, we have shown the presence of functional integration between brain regions in BOLD signal frequencies higher than 0.1 Hz (Gohel et al. 2015).
These results have further led to quantification of frequency-specific differences in BOLD signal power in drug-naive schizophrenia patients compared to healthy volunteers (Gohel et al., 2018). Secondarily, our research focuses on using advanced neuroimaging data collection and analytical strategies to understand functional brain disruptions in clinical populations. We have successfully used functional neuroimaging to quantify brain disruptions in a variety of neurological disorders, including brain injury, (Gohel, Bharath et al., 2015), and brain tumors (Gohel et al. 2019) as well as mental health disorders including addiction (Filbey, Gohel, et al., 2018) and psychosis (Gohel et al., 2018).
Finally, we also focus on methods of development for quantifying neuronal and neurophysiological components of BOLD fMRI signal and its disruptions in clinical population.